Volpara signs second lung screening partnership
UPDATE: Volpara aims to emulate breast cancer success as lung screening takes off.
Nicola Shepheard
Mon, 20 Sep 2021
Hot Topic
NBR Focus: The Accountants 2024
UPDATE: Volpara Health Technologies has formed a partnership with US-based lung AI company, RevealDx, the second strategic play announced this month by the ASX-listed, Wellington-based cancer detection medtech to accelerate its move into the lung cancer screening market after establishing itself as
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Nicola Shepheard
Mon, 20 Sep 2021
Contact the Writer: nicola@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Volpara signs second lung screening partnership
Business,
88922